The Checklist for Healthcare Professionals is an aid to help you evaluate and discuss the risks associated with glycopyrronium bromide 1 mg/5 ml oral solution with the patient’s carer. It provides important information on the management and minimisation of side effects.

The Reminder Card for Caregivers should be handed to patient’s parents/caregivers. The dosing table on the Reminder Card for Caregivers should be completed by the physician with the proposed dose at each dose change. 

Reminder card for Caregivers of Glycopyrronium Bromide 1 mg and 2 mg Tablets.

These materials have been designed to support you in the appropriate administration of Glycopyrronium Bromide 1 mg and 2 mg Tablets for the symptomatic treatment of severe sialorrhoea (chronic pathological drooling) in children and adolescents aged 3 years and older with chronic neurological disorders.

It is recommended that these materials be used in conjunction with the full prescribing information for the product.

Educational materials for Glycopyrronium Bromide 1 mg and 2 mg Tablets. These materials have been designed to support you in the appropriate prescription and administration of Glycopyrronium Bromide 1 mg and 2 mg Tablets for the symptomatic treatment of severe sialorrhoea (chronic pathological drooling) in children and adolescents aged 3 years and older with chronic neurological disorders.

It is recommended that these materials be used in conjunction with the full prescribing information for the product.

Checklist for healthcare professionals to remind the prescriber about the risks associated with use of glycopyrronium bromide in the paediatric population and to highlight important information to the prescriber, which are to be brought to the attention of the patient/caregiver.

Glycopyrronium bromide 2mg/5ml Oral Solution - Reminder Card for Caregivers:

For distribution by the prescribing healthcare professional on a voluntary basis to support the parent/caregiver in recognising the risks associated with use of glycopyrronium bromide in the paediatric population and to provide information about administration, management and minimisation of anticholinergic reactions.